/>

Wednesday, October 31, 2018

NEWS 31 OCT 2018

NEWS FROM USA

NDA Approvals        

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

19 Oct 2018

Meloxicam Disintegrating Tablets

Tersera

Qmiiz ODT 

Label

28 Oct 2018

Estradiol;Progesterone Capsule

Therapeuticsmd 

Bijuva

Label

 

 

ANDA Approvals 

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

26 Oct 2018

Teriflunomide Tablets

Aurobindo 

Aubagio (Sanofi )

Three

26 Oct 2018

Felodipine ER Tablets

Yiling Pharm 

N/A

Ten

26 Oct 2018

Progesterone Capsule

Eugia 

Prometrium (Virtus)

Six

26 Oct 2018

Clobetasol Propionate Lotion

Hi-Tech 

Clobex (Galderma )

Four

26 Oct 2018

Albuterol Sulfate Tablets

Novitium 

N/A

Four

26 Oct 2018

Quetiapine Fumarate ER Tablets

Amneal 

Seroquel XR (Astrazeneca)

Ten

26 Oct 2018

Methocarbamol Solution

Gland Pharma 

Robaxin (West-Ward)

Nine

26 Oct 2018

Liothyronine Sodium Tablets

Teva 

Cytomel (King)

Four

29 Oct 2018

Midodrine Hydrochloride Tablets

Par Pharm 

N/A

Five

30 Oct 2018

Glycopyrrolate Tablets

Aurolife 

N/A

Nine

30 Oct 2018

Fluocinolone Acetonide Topical Oil (Scalp Oil)

Glenmark

Derma-Smoothe/FS (Hill Dermaceuticals)

Ten

                                               

Tentative ANDA Approvals                       

Approval Date

Drug

Company

26 Oct 2018

Methylergonovine Maleate

Teva 


 

NEW GENERICS LAUNCHES IN US

 

DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Atomoxetine Capsule 

DR Reddy

Strattera (Eli Lilly)

$ 304 Million

Link

 

USFDA Inspection

 

Dr Reddy's gets 8 observations from USFDA for Duvvada plant

                                               

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

                                                                

Monday, October 29, 2018

NEWS 29 OCT 2018

|

NEWS FROM USA

ANDA Approvals 

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

25 Oct 2018

Fluocinolone Acetonide Topical Oil

Glenmark 

Derma-Smoothe/Fs (Hill Dermac)

Nine

26 Oct 2018

Clobetasol Propionate Lotion

Akorn

Clobex (Galderma )

Four

29 Oct 2018

Metoprolol Succinate ER Tablets

Cipla

Toprol XL (Aralez Pharma)

Seven

 

Tentative ANDA Approvals                       

Approval Date

Drug

Company

24 Oct 2018

Temsirolimus

Gland 

 

 

USFDA Inspection

 

USFDA completed inspection in Granules pharmaceuticals

                                               

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

                                                                

Friday, October 26, 2018

NEWS 26 OCT 2018

NEWS FROM USA

NDA Approvals        

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

24 Oct 2018

Baloxavir Marboxil Tablets

Shionogi 

Xofluza

Label

 

ANDA Approvals 

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

24 Oct 2018

Dalfampridine ER Tablets

West-Ward 

Ampyra (Acorda)

Four

24 Oct 2018

Acetaminophen; Hydrocodone Bitartrate Tablets

Alvogen Pine 

None

Fourteen

 

NEW GENERICS LAUNCHES IN US

 

DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Arsenic Trioxide Injection 

Fresenius Kabi

Trisenox (Cephalone)

N/A

Link

                                               

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

                                                                

Wednesday, October 24, 2018

NEWS 24 OCT 2018

NEWS FROM USA

NDA Approvals        

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

19 Oct 2018

Levoleucovorin Injection

Spectrum Pharms

Khapzory

Link

Earlier approved Levoleucovorin was calcium salt

 

ANDA Approvals 

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

17 Oct 2018

Lansoprazole Dr Capsule

Breckenridge Pharm

Prevacid (Takeda)

Thirteen

17 Oct 2018

Adapalene; Benzoyl Peroxide Topical Gel

Taro

Epiduo Forte (Galderma)

None

17 Oct 2018

Cefazolin Sodium Injection

Qilu Pharm 

N/A

Five

17 Oct 2018

Ceftriaxone Sodium Injection

Qilu Pharm 

N/A

Six

17 Oct 2018

Isoproterenol Hydrochloride Injection

Amneal Pharms 

Isuprel (Hospira)

Three

18 Oct 2018

Capreomycin Sulfate Injection

Hisun Pharm 

Capastat Sulfate (Akorn)

One (Mylan)

18 Oct 2018

Acetazolamide Er Capsule

Accord Hlthcare

Diamox (Teva)

Four

18 Oct 2018

Norepinephrine Bitartrate Injection

Sandoz

Levophed (Hospira)

Four

20 Oct 2018

Gabapentin Capsule

Strides

Neurontin (Pfizer)

Fifteen

22 Oct 2018

Clobazam Tablets

West-Ward Pharma

Onfi (Lundbeck)

All the generics were approved on the same date as Onfi’s ODE expired on 21 Oct 2018

Eight

22 Oct 2018

Clobazam Suspension

Bionpharma 

Four

22 Oct 2018

Clobazam Tablets

Bionpharma 

Eight

22 Oct 2018

Clobazam Tablets

Breckenridge  

Eight

22 Oct 2018

Clobazam Tablets

Taro Pharm

Eight

22 Oct 2018

Clobazam Tablets

Upsher-Smith 

Eight

22 Oct 2018

Clobazam Suspension

West-Ward 

Four

22 Oct 2018

Clobazam Tablets

Amneal 

Eight

22 Oct 2018

Clobazam Tablets

Hetero Labs  

Eight

22 Oct 2018

Clobazam Tablets

Piramal 

Eight

22 Oct 2018

Clobazam Suspension

Amneal 

Four

22 Oct 2018

Clobazam Suspension

Upsher

Four

22 Oct 2018

Clobazam Suspension

Mylan 

Four

22 Oct 2018

Clobazam Tablets

Zydus 

Eight

22 Oct 2018

Triamcinolone Acetonide Ointment 

Lupin

Triamcinolone Acetonide Ointment (Mylan)

Eleven

*Highlighted products are the 1st generics approval for the corresponding RLD

 

Tentative ANDA Approvals           

Approval Date

Drug

Company

12 Oct 2018

Alogliptin

Alembic

12 Oct 2018

Mifepristone

Teva

15 Oct 2018

Benzoyl Peroxide;Clindamycin Phosphate

Tolmar

16 Oct 2018

Fesoterodine Fumarate

Torrent

16 Oct 2018

Colchicine

Zydus

19 Oct 2018

Tadalafil

Amneal 

 

NEW GENERICS LAUNCHES IN US

 

DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Medroxyprogesterone Acetate Injectable Suspension 

Mylan

Depo-Provera (Pfizer)

$ 181 Million

Link

Isoproterenol Hydrochloride

Amneal

Isuprel (HOSPIRA )

$158 Million

Link

Carmustine

Amneal

BiCNU (Emcure)

$84 Million

Link

Clobazam Tablets

Amneal

Onfi (Lundbeck)

$594 Million

Link

Clobazam Tablets

Camber (Hetero)

Onfi (Lundbeck)

$594 Million

Link

Clobazam Tablets

Bionpharma

Onfi (Lundbeck)

$594 Million

Link

Clobazam Suspension

Amneal

Onfi (Lundbeck)

$255 Million

Link

Clobazam Suspension

Bion pharma

Onfi (Lundbeck)

$255 Million

Link

 

USFDA INSPECTION

Lupin's Pithampur Unit-3 (Indore) Inspected by US FDA

 

NEWS FROM EUROPE

Positive CHMP opinions (EMA)

Drug

Sponsor

Indication

Mexiletine Hydrochloride

Lupin

Myotonia In Non-Dystrophic Myotonic Disorders

Ivacaftor

Vertex Pharma

Treat Patients With Cystic Fibrosis Aged 12 to <24 Months

 

Other News from Europe

·         Mylan and Biocon Announce Positive CHMP Opinion for Ogivri, Biosimilar Trastuzumab 

·         Mylan Launches Hulio (Biosimilar Adalimumab) in Markets Across Europe

 

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com